- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05689385
eHealth-based Cardiac Rehabilitation in Post-myocardial Infarction Patients
The Effectiveness of eHealth-based Cardiac Rehabilitation in Post-myocardial Infarction Patients:a Randomized Controlled Trial.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Cardiac rehabilitation can improve exercise capacity, life of quality, readmission rate and mortality rate for patients after myocardial infarction. International guidelines list cardiac rehabilitation after myocardial infarction as class IA recommendation. However, low participation rate of cardiac rehabilitation due to barriers such as lacking of time, transport or affordability issues is an unsolved problem worldwide.
eHealth, consisting of telemedicine, mobile health and personalized care using wearable devices has the potential to remove the barriers and become an effective model to deliver cardiac rehabilitation. Thus, we design a randomized controlled trial to compare the effect of a case manager-led eHealth-based cardiac rehabilitation program with usual care on the compliance, physical activity, quality of life, and cardiorespiratory fitness in patients after myocardial infarction.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Hung-Jui Chuang, MD
- Phone Number: 67034 00886-2-23123456
- Email: 103311@ntuh.gov.tw
Study Locations
-
-
-
Taipei, Taiwan
- Recruiting
- National Taiwan University Hospital
-
Contact:
- Hung-Jui Chuang, MD
- Phone Number: 67034 00886-2-23123456
- Email: Rexintwo@gmail.com
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion criteria:
- ≥ 20 years of age.
- Within 6 months after the onset of acute myocardial infarction.
- At lowest to moderate risk according to the guideline from American Association of Cardiovascular and Pulmonary Rehabilitation.
- Unable or refused to attend center-based cardiac rehabilitation.
Exclusion criteria:
- Unable to walk independently or use a stationary bike.
- Unable to follow verbal command.
- Not having a smartphone which can get on the internet.
- Having contraindications for exercise according to American College of Sports Medicine's Guidelines for Exercise Testing and Prescription.
- Unable to provide informed consent.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: eHealth-based cardiac rehabilitation
Participants receive a 12-wk case manager-led eHealth-based cardiac rehabilitation program with follow-up at 12 week, 6 months and 12 months.
|
The 12-wk case manager-led eHCR program includes:
Other Names:
|
No Intervention: Usual care
Participants receive usual care.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change of peak oxygen uptake
Time Frame: at baseline, 12 weeks(post-intervention), and 12 months.
|
Peak oxygen uptake will be assessed using cardiopulmonary exercise test before intervention, at 12 weeks (post-intervention), and at 12 months.
|
at baseline, 12 weeks(post-intervention), and 12 months.
|
Change of ventilatory anaerobic threshold
Time Frame: at baseline, 12 weeks(post-intervention), and 12 months.
|
Ventilatory anaerobic threshold will be assessed using cardiopulmonary exercise test before intervention, at 12 weeks (post-intervention), and at 12 months.
|
at baseline, 12 weeks(post-intervention), and 12 months.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Adherence to prescribed exercise
Time Frame: at 12 weeks(post-intervention) and 12 months.
|
The degree of completion of prescribed exercise will be assessed at 12 weeks and 12 months.
|
at 12 weeks(post-intervention) and 12 months.
|
Evaluation of Quality of life
Time Frame: at baseline, 12 weeks(post-intervention), and 12 months.
|
The investigators will assess the change in 36-Item Short Form Survey(SF-36).
|
at baseline, 12 weeks(post-intervention), and 12 months.
|
Depression
Time Frame: at baseline, 12 weeks(post-intervention), and 12 months.
|
The investigators will assess the change in Patient Health Questionnaire (PHQ-9).
The PHQ-9 score ranges from 0-27.
Higher scores indicate worsen symptoms.
|
at baseline, 12 weeks(post-intervention), and 12 months.
|
Anxiety
Time Frame: at baseline, 12 weeks(post-intervention), and 12 months.
|
The investigators will assess the change in Generalized Anxiety Disorder scale (GAD-7).
The GAD-7 score ranges 0-21.
Higher scores indicate worsen symptoms.
|
at baseline, 12 weeks(post-intervention), and 12 months.
|
Evaluation of physical activity
Time Frame: at baseline, 12 weeks(post-intervention), and 12 months.
|
The investigators will assess the change in physical activity using Long form International Physical Activity Questionnaire(IPAQ) Taiwan version.
|
at baseline, 12 weeks(post-intervention), and 12 months.
|
Evaluation of grip strength
Time Frame: at baseline, 12 weeks(post-intervention), and 12 months.
|
The grip strength will be measured using a grip goniometer with the participants seated and the elbow flexed at 90 degrees.
|
at baseline, 12 weeks(post-intervention), and 12 months.
|
Evaluation of isometric knee extension strength
Time Frame: at baseline, 12 weeks(post-intervention), and 12 months.
|
The isometric knee extension strength will be measured using a dynamometer with participants seated and knee flexed at 90 degrees.
|
at baseline, 12 weeks(post-intervention), and 12 months.
|
Collaborators and Investigators
Investigators
- Principal Investigator: Hung-Jui Chuang, MD, Department of Physical Medicine and Rehabilitation, National Taiwan University Hospital
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 202207060RINC
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Myocardial Infarction
-
Azienda ULSS 5 PolesanaUniversity of PadovaUnknownMyocardial Infarction, Acute | ST Segment Elevation Myocardial Infarction | Non-ST Elevation Myocardial Infarction (nSTEMI)Italy
-
University Medical Centre LjubljanaCompletedCardiac Arrest | Postresuscitation Syndrome | Myocardial Infarction (ST-Elevation Myocardial Infarction and Non-ST-Elevation Myocardial Infarction)Slovenia
-
Fundacio Privada Mon Clinic BarcelonaMiracor Medical SANot yet recruiting
-
Stiftung Institut fuer HerzinfarktforschungGlaxoSmithKline; University Hospital Muenster; Klinikum NürnbergCompletedMyocardial Infarction | ST-Elevation Myocardial Infarction | Non-ST-Elevation Myocardial InfarctionGermany
-
Bispebjerg HospitalOdense University Hospital; Zealand University Hospital; Hvidovre University... and other collaboratorsRecruitingST Elevation Myocardial Infarction | Acute Myocardial Infarction | Non-ST Elevation Myocardial Infarction (nSTEMI)Denmark
-
Population Health Research InstituteCanadian Institutes of Health Research (CIHR); Boston Scientific CorporationActive, not recruitingST Elevation Myocardial Infarction | Non ST Elevation Myocardial InfarctionCanada
-
University of LeedsUniversity College, LondonCompletedST-elevation Myocardial Infarction | Non ST-elevation Myocardial Infarction
-
Karolinska InstitutetUppsala University; The Swedish Research CouncilActive, not recruitingST Elevation Myocardial Infarction | Acute Myocardial Infarction | Non-ST Elevation Myocardial InfarctionSweden
-
Oslo University HospitalVestre Viken Hospital Trust; University of Oslo; University Hospital of North... and other collaboratorsActive, not recruitingST Elevation Myocardial Infarction | Acute Myocardial Infarction | Non-ST Elevation Myocardial InfarctionNorway
-
Barts & The London NHS TrustUniversity College, London; Queen Mary University of LondonCompletedAcute Myocardial InfarctionSwitzerland, Denmark, United Kingdom
Clinical Trials on eHealth-based cardiac rehabilitation
-
Federico II UniversityCompletedAcute Myocardial InfarctionItaly
-
Universidade Estadual Paulista Júlio de Mesquita...CompletedCardiovascular Diseases | Cardiac Risk FactorsBrazil
-
Mayo ClinicJohns Hopkins University; University of California, Irvine; University of Mississippi...Not yet recruitingCardiovascular Diseases | Telemedicine | Cardiac EventUnited States
-
Universidade do PortoCentro Hospitalar de Vila Nova de Gaia/Espinho; Research Center in Physical...CompletedCoronary Artery DiseasePortugal
-
University of ChesterUniversity Hospitals of Derby and Burton NHS Foundation TrustCompletedCardiovascular DiseasesUnited Kingdom
-
Maxima Medical CenterCompletedMyocardial Infarction | Acute Coronary SyndromeNetherlands
-
Université de SherbrookeActive, not recruiting
-
Universidade Estadual Paulista Júlio de Mesquita...RecruitingCardiovascular Diseases | Cardiovascular Risk FactorBrazil
-
Washington University School of MedicineThe Foundation for Barnes-Jewish HospitalRecruitingSarcoma | Breast Cancer | Hodgkin Disease | Hodgkin Lymphoma | Esophageal Cancer | Thymoma | Lung Cancer | Thoracic Cancer | Non-hodgkin LymphomaUnited States
-
Taichung Veterans General HospitalCompletedHeart Failure With or Without CRT-P/D